# Valion Bio, Inc.

Type: Company (VBIO)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/valion-bio-inc
Canonical HTML page: https://gethealthbrief.com/entity/valion-bio-inc

## Timeline

- **2026-08-13**: Valion Bio announces technical assessment underway — Valion Bio issued a press release stating the Ministry has begun technical assessment and issued a first round of questions on physicochemical characterization.
- **2026-07-22**: Ukraine MOH accepts Entolimod dossier — Ukraine's Ministry of Health accepted Valion Bio's regulatory dossier for Entolimod for formal review under the Regulatory Equivalence Pathway.

## Recent coverage (1 stories)

### Valion Bio: 1st National Registration Looms as Ukraine MOH Reviews Entolimod
2026-08-13 17:36:16 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Ukraine's Ministry of Health has moved Valion Bio's Entolimod dossier into technical assessment, a step toward what would be the drug's first national registration as an acute radiation syndrome countermeasure. The company says a decision could come as early as Q4 2026, though no procurement or stockpiling agreement exists.
Full story: https://gethealthbrief.com/story/ukraine-moh-entolimod-technical-assessment-valion-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.